TVAGF yields 235.29% · PFE yields 6.13%● Live data
📍 TVAGF pulled ahead of the other in Year 1
Combined, TVAGF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TVAGF + PFE for your $10,000?
TVA Group Inc. operates a communications company in Canada. It operates through four segments: Broadcasting, Magazines, Film Production & Audiovisual Services, and Production & Distribution. The company's Broadcasting segment creates, produces, and broadcasts entertainment, sports, news, and public affairs programming, as well as engages in commercial production; operates a French-language television network; markets digital products associated with various televisual brands; and provides custom publishing and specialty services. Its Magazines segment publishes magazines in various fields, such as the arts, entertainment, television, fashion, and decoration; and markets digital products associated with various magazine brands. The company's Film Production & Audiovisual Services segment offers soundstage, mobile, and equipment rental services, as well as dubbing and described video, postproduction and visual effects. Its Production & Distribution segment produces and distributes television shows, movies, and television series worldwide. The company was formerly known as Télé-Métropole Inc. and changed its name to TVA Group Inc. in February 1998. TVA Group Inc. was incorporated in 1960 and is headquartered in Montreal, Canada. TVA Group Inc. is a subsidiary of Quebecor Media Inc.
Full TVAGF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.